Inhibition of phospholipase A2 by Virasole derivation
https://doi.org/10.29235/1561-8323-2021-65-3-309-319
Abstract
Kinetics of phosphatidylcholine (PC) hydrolysis under the action of pancreatic phospholipase A2 IB, (EC 3.1.1.4, PLA2) in the presence of a lipophilic derivative of the antiviral drug Virazole 1-(3-((tert-butyldimethylsilyl)oxy)-4-hydroxy-5- (((4-methoxyphenyl)diphenylmethoxy)methyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide (Virazole2ЗГ) was studied. The both steps of phospholipolysis were quantitatively characterized: the binding of the enzyme to the lipid-water interface (Ks) and directly the catalytic act (Km) with the determination of the maximum reaction rate (Vmax). It was found that Virazole2ЗГ at a concentration of 0.5 μmol/ml does not affect the Ks value; on the contrary, the Michaelis constant, Km, increases by a factor of 1.8 along with the constancy of the parameter Vmax. Based on the constancy of the Ks values, it seems to be assumed that there is no inhibition of the disintegration of the enzyme-micelle complex in the presence of the effector under the studied reaction conditions. The kinetic parameters of the reaction (the increase in Km and the constancy of Vmax in the presence of Virazole2ЗГ) testify in favor of a moderate competitive inhibition of pancreatic PLA2, Ki = 65 mM, which indicates the possibility of searching for the biological activity of the anti-pancreatitis action in the series of pro-drugs of nucleoside nature.
About the Author
N. M. Litvinko
Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus
Belarus
Belarus
Litvinko Natalia M. – D. Sc. (Chemistry), Assistant Professor, Head of the Laboratory
5/2, Kuprevich Str., 220141, Minsk, Republic of Belarus
References
1. Murakami M. Novel functions of phospholipase A2s: Overview. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids, 2019, vol. 1864, no. 6, pp. 763–765. https://doi.org/10.1016/j.bbalip.2019.02.005
2. Tappia P. S., Dhalla N. S. Phospholipases in Health and Disease. New York, 2014. 410 p. https://doi.org/10.1007/978-1-4939-0464-8
3. Nikolaou A., Kokotou M. G., Vasilakaki S., Kokotos G. Small-molecule inhibitors as potential therapeutics and as tools to understand the role of phospholipases A2. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids, 2019, vol. 1864, no. 6, pp. 941–956. https://doi.org/10.1016/j.bbalip.2018.08.009
4. Pedada S. R., Yarla N. S., Tambade P. J., Dhananjaya B. L., Bishayee A., Arunasree K. M., Philip G. H., Dharmapuri G., Aliev G., Putta S., Rangaiah G. Synthesis of new secretory phospholipase A2-inhibitory indole containing isoxazole derivatives as anti-inflammatory and anticancer agents. European Journal of Medicinal Chemistry, 2016, vol. 112, pp. 289–297. https://doi.org/10.1016/j.ejmech.2016.02.025
5. Giordanetto F., Pettersen D., Starke I., Nordberg P., Knerr L., Selmi N., Rosengren B., Larsson L.-O., Sandmark J., Castaldo M., Dekker N., Karlson U., Hurt-Camejo E. Discovery of AZD2716: a novel secreted phospholipase A2 (sPLA2) inhibitor for the treatment of coronary artery disease. ACS Medicinal Chemistry Letters, 2016, vol. 7, no. 10, pp. 884–889. https://doi.org/10.1021/acsmedchemlett.6b00188
6. Vasilakaki S., Barbayianni E., Leonis G., Papadopoulos M. G., Mavromoustakos T., Gelb M. H., Kokotos G. Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations. Bioorganic and Medicinal Chemistry, 2016, vol. 24, no. 8, pp. 1683–1695. https://doi.org/10.1016/j.bmc.2016.02.040
7. Alasmary F., Alnahdi F. S., Bacha A. B., El-Araby A. M., Moubayed N., Alafeefy A. M., El-Araby M. E. New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017, vol. 32, no. 1, pp. 1143–1151. https://doi.org/10.1080/14756366.2017.1363743
8. Xing M., Firestein B. L., Shen G. H., Insel P. A. Dual role of protein kinase C in the regulation of cPLA2-mediated arachidonic acid release by P2U receptors in MDCK–D1 cells: involvement of MAP kinase-dependent and -independent pathways. Journal of Clinical Investigation, 1997, vol. 99, no. 4, pp. 805–814. https://doi.org/10.1172/jci119227
9. Bany B. M., Schultz G. A., Kennedy T. G. Regulation of cytosolic phospholipase A2 in rat endometrial stromal cells: the role of epidermal growth factor. Molecular Reproduction and Development, 1999, vol. 52, no. 4, pp. 335–340. https://doi.org/10.1002/(sici)1098-2795(199904)52:4%3C335::aid-mrd1%3E3.0.co;2-f
10. Litvinko N. M., Drozhdenok A. P. Complexation of phospholipase A2 with nucleic acid fragments and methods for their elimination. Prikladnaya biokhimiya i mikrobiologiya [Applied Biochemistry and Microbiology], 1996, vol. 32, no. 6, pp. 650–655 (in Russian).
11. Litvinko N. M., Kuchuro S. V., Rakhuba G. N., Skorostetskaya L. A., Kalinichenko E. N., Zhernosek E. V. Effect of phospholipases on chimeric substrates based on phospholipids and nucleic acid components. Doklady Akademii nauk Belarusi = Doklady of the Academy of Sciences of Belarus, 2005, vol. 49, no. 4, pp. 70–73 (in Russian).
12. Gerlovsky D. O., Litvinko N. M., Skorostetskaya L. A., Kuchuro S. V., Kalinichenko E. N., Farina A. V. Phosphodiester of acyclovir – new inhibitors of pancreatic phospholipase A2. Doklady Natsional’noi akademii nauk Belarusi = Doklady of the National Academy of Sciences of Belarus, 2010, vol. 54, no. 1, pp. 75–82 (in Russian).
13. Assogba L., Ahamada-Himidi A., Meddad-Bel Habich N., Aoun D., Boukli L., Massicot F., Mounier C. M., Huet J., Lamouri A., Ombetta J.-E., Godfroid J.-J., Dong C.-Z., Heymans F. Inhibition of secretory phospholipase A2. 1-Design, synthesis and structure–activity relationship studies starting from 4-tetradecyloxybenzamidine to obtain specific inhibitors of group II sPLA2s. European Journal of Medicinal Chemistry, 2005, vol. 40, no. 9, pp. 850–861. https://doi.org/10.1016/j.ejmech.2005.03.027
14. Deems R. A., Eaton B. R., Dennis E. A. Kinetic analysis of phospholipase A2 activity toward mixed micelles and its implications for the study of lipolytic enzymes. Journal of Biological Chemistry, 1975, vol. 250, no. 23, pp. 9013–9020. https://doi.org/10.1016/s0021-9258(19)40687-x
15. Litvinko N. M., Gerlovsky D. O., Kuchuro S. V., Kalinichenko E. N., Kulak T. I., Oleinikova I. A. Effect of ribavirin derivatives on catalysis of lipolytic reactions. Molekulyarnye, membrannye i kletochnye osnovy funktsionirovaniya biosistem: cbornik nauchnykh trudov IX s’ezda Belorusskogo obshchestvennogo ob’edineniya fotobiologov i biofizikov, 23–25 iyunya 2010 g. [Molecular, membrane and cellular bases of the functioning of biosystems: collection of scientific papers of the IX Congress of the Belarusian Public Association of Photobiologists and Biophysicists, June 23–25, 2010]. Minsk, 2010, pp. 240–242 (in Russian).
16. Bergelson L. D., Dyatlovitskaya E. V., Motolkovski Yu. G. Preparative biochemistry of lipids. Moscow, 1981 (in Russian).
17. Vaskovsky V. E., Kostetsky E. Y., Vasendin I. M. A universal reagent for phospholipid analysis. Journal of Chromatography, 1975, vol. 114, no. 1, pp. 129–141. https://doi.org/10.1016/s0021-9673(00)85249-8
18. Webb L. Enzyme and metabolic inhibitors. Academic Press, 1963. 1028 p. https://doi.org/10.5962/bhl.title.7320
19. Rakhuba G. N. Lipolytic reactions with the participation of phospholipases A2 and mechanisms of their regulation according to the principle of feedback. Minsk, 2007. 143 p. (in Russian).
20. Lyakh A. V., Litvinko N. M., Mikhailopulo I. A., Gerlovsky D. O. PLA2 Activity in the Presence of Modified Nucleoside Analogs. Materialy Mezhdunarodnoi nauchno-prakticheskoi konferentsii «Biotekhnologii mikroorganizmov», posvyashchennoi professoru Yu. K. Fomichevu (1929–2015) [Materials of the International Scientific and Practical Conference “Biotechnology of Microorganisms” dedicated to Professor Yu. K. Fomichev (1929–2015)]. Minsk, 2019, pp. 368–370 (in Russian).
21. Verheij H. M., Egmond M. R., De Haas G. H. Chemical Modification of the alpha-Amino Group in Snake Venom Phospholipases A2. A Comparison of the Interaction of Pancreatic and Venom Phospholipases with Lipid–Water Interfaces. Biochemistry, 1981, vol. 20, no. 1, pp. 94–99. https://doi.org/10.1021/bi00504a016
22. Bragina N. A., Chupin V. V., Bulgakov V. G., Shalnev A. N. Lipid inhibitors of phospholipase A2. Russian Journal of Bioorganic Chemistry, 1999, vol. 25, no. 2, pp. 67–80.
Review
Views: 958
Email this article 